Meisner A - Search Results

1

Combining biomarkers by maximizing the true positive rate for a fixed false positive rate.

Meisner A, Carone M, Pepe MS, Kerr KF. Meisner A, et al. Biom J. 2021 Aug;63(6):1223-1240. doi: 10.1002/bimj.202000210. Epub 2021 Apr 19. Biom J. 2021. PMID: 33871887 Free PMC article.

2

Developing risk prediction models for kidney injury and assessing incremental value for novel biomarkers.

Kerr KF, Meisner A, Thiessen-Philbrook H, Coca SG, Parikh CR. Kerr KF, et al. Among authors: meisner a. Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1488-96. doi: 10.2215/CJN.10351013. Epub 2014 May 22. Clin J Am Soc Nephrol. 2014. PMID: 24855282 Free PMC article. Review.

3

Evaluating biomarkers for prognostic enrichment of clinical trials.

Kerr KF, Roth J, Zhu K, Thiessen-Philbrook H, Meisner A, Wilson FP, Coca S, Parikh CR. Kerr KF, et al. Among authors: meisner a. Clin Trials. 2017 Dec;14(6):629-638. doi: 10.1177/1740774517723588. Epub 2017 Aug 10. Clin Trials. 2017. PMID: 28795578 Free PMC article.

4

Biomarker combinations for diagnosis and prognosis in multicenter studies: Principles and methods.

Meisner A, Parikh CR, Kerr KF. Meisner A, et al. Stat Methods Med Res. 2019 Apr;28(4):969-985. doi: 10.1177/0962280217740392. Epub 2017 Nov 20. Stat Methods Med Res. 2019. PMID: 29157119 Free PMC article.

5

Using ordinal outcomes to construct and select biomarker combinations for single-level prediction.

Meisner A, Parikh CR, Kerr KF. Meisner A, et al. Diagn Progn Res. 2018 May 21;2:8. doi: 10.1186/s41512-018-0028-3. eCollection 2018. Diagn Progn Res. 2018. PMID: 31093558 Free PMC article.

6

Developing biomarker combinations in multicenter studies via direct maximization and penalization.

Meisner A, Parikh CR, Kerr KF. Meisner A, et al. Stat Med. 2020 Oct 30;39(24):3412-3426. doi: 10.1002/sim.8673. Epub 2020 Aug 13. Stat Med. 2020. PMID: 32794249 Free PMC article.

7

Development of biomarker combinations for postoperative acute kidney injury via Bayesian model selection in a multicenter cohort study.

Meisner A, Kerr KF, Thiessen-Philbrook H, Wilson FP, Garg AX, Shlipak MG, Kavsak P, Whitlock RP, Coca SG, Parikh CR. Meisner A, et al. Biomark Res. 2018 Jan 12;6:3. doi: 10.1186/s40364-018-0117-z. eCollection 2018. Biomark Res. 2018. PMID: 29344362 Free PMC article.

8

RiGoR: reporting guidelines to address common sources of bias in risk model development.

Kerr KF, Meisner A, Thiessen-Philbrook H, Coca SG, Parikh CR. Kerr KF, et al. Among authors: meisner a. Biomark Res. 2015 Jan 24;3(1):2. doi: 10.1186/s40364-014-0027-7. eCollection 2015. Biomark Res. 2015. PMID: 25642328 Free PMC article.

9

Urinalysis findings and urinary kidney injury biomarker concentrations.

Nadkarni GN, Coca SG, Meisner A, Patel S, Kerr KF, Patel UD, Koyner JL, Garg AX, Philbrook HT, Edelstein CL, Shlipak M, El-Khoury J, Parikh CR; TRIBE-AKI Consortium Investigators. Nadkarni GN, et al. Among authors: meisner a. BMC Nephrol. 2017 Jul 6;18(1):218. doi: 10.1186/s12882-017-0629-z. BMC Nephrol. 2017. PMID: 28683730 Free PMC article.

10

Methodological issues in current practice may lead to bias in the development of biomarker combinations for predicting acute kidney injury.

Meisner A, Kerr KF, Thiessen-Philbrook H, Coca SG, Parikh CR. Meisner A, et al. Kidney Int. 2016 Feb;89(2):429-38. doi: 10.1038/ki.2015.283. Kidney Int. 2016. PMID: 26398494 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page